GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » EV-to-EBITDA

Incannex Healthcare (STU:IQI) EV-to-EBITDA : -1.40 (As of May. 21, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Incannex Healthcare EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Incannex Healthcare's enterprise value is €19.65 Mil. Incannex Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €-14.07 Mil. Therefore, Incannex Healthcare's EV-to-EBITDA for today is -1.40.

The historical rank and industry rank for Incannex Healthcare's EV-to-EBITDA or its related term are showing as below:

STU:IQI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -56.56   Med: -1.58   Max: -0.13
Current: -2.07

During the past 13 years, the highest EV-to-EBITDA of Incannex Healthcare was -0.13. The lowest was -56.56. And the median was -1.58.

STU:IQI's EV-to-EBITDA is ranked worse than
100% of 711 companies
in the Drug Manufacturers industry
Industry Median: 14.89 vs STU:IQI: -2.07

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Incannex Healthcare's stock price is €0.028. Incannex Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.006. Therefore, Incannex Healthcare's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Incannex Healthcare EV-to-EBITDA Historical Data

The historical data trend for Incannex Healthcare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare EV-to-EBITDA Chart

Incannex Healthcare Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.59 -3.41 -3.87 -19.32 -17.07

Incannex Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.87 -7.09 -6.77 -4.60 -3.14

Competitive Comparison of Incannex Healthcare's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Incannex Healthcare's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Incannex Healthcare's EV-to-EBITDA falls into.



Incannex Healthcare EV-to-EBITDA Calculation

Incannex Healthcare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=19.650/-14.065
=-1.40

Incannex Healthcare's current Enterprise Value is €19.65 Mil.
Incannex Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incannex Healthcare  (STU:IQI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Incannex Healthcare's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.028/-0.006
=At Loss

Incannex Healthcare's share price for today is €0.028.
Incannex Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.006.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Incannex Healthcare EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Incannex Healthcare (STU:IQI) Business Description

Traded in Other Exchanges
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.